🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare the efficacy and safety of the fixe...
Status
Completed
Location
Research Center
Start Date
2006-06
Trial ID
NCT00393952
The purpose of this study is to evaluate the safety and the efficacy of Gly...
Status
Completed
Location
Medicines Evaluation Unit
Start Date
2010-08
Trial ID
NCT01176903
Treatments Being Tested
The purpose of this study is to test the body's response to several doses o...
Status
Completed
Location
Quotient Clinical Ltd
Start Date
2014-07
Trial ID
NCT02232087
Treatments Being Tested
This is a randomized, single-blind, placebo-controlled, sequential-group st...
Status
Completed
Location
Research Site
Start Date
2016-01-12
Trial ID
NCT02645253
The purpose of this study is to evaluate the efficacy of Fixed Combination ...
Status
Completed
Location
Medical Center Convex EOOD
Start Date
2018-06-15
Trial ID
NCT03590379
Treatments Being Tested
The purpose of this study is to determine whether Symbicort dosed according...
Status
Completed
Location
Research Site
Start Date
2004-12
Trial ID
NCT00252863
Treatments Being Tested
A randomized clinical study to assess the impact of Symbicort® pMDI medicat...
Status
Completed
Location
Research Site
Start Date
2016-08-12
Trial ID
NCT02864342
Treatments Being Tested
This is a variable length study to evaluate the efficacy and safety of bude...
Status
Completed
Location
Research Site
Start Date
2021-03-01
Trial ID
NCT04609904
Treatments Being Tested
The purpose of the study is to assess the propellants,1 - Difluoroethane \[...
Status
Completed
Location
GSK Investigational Site
Start Date
2025-03-11
Trial ID
NCT06702462
Treatments Being Tested
The study is being conducted to compare the pharmacokinetic (PK) of BDP (an...
Status
Completed
Location
SGS Belgium NV - Clinical Pharmacology Unit
Start Date
2023-04-24
Trial ID
NCT05898984